• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低三碘甲状腺原氨酸综合征与硒缺乏——在晚期心力衰竭中被低估的角色?一项单中心的初步研究。

Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study.

机构信息

Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, Krakow, Poland.

Department of Emergency Medical Care, Jagiellonian University Medical College, Krakow, Poland.

出版信息

BMC Cardiovasc Disord. 2019 May 7;19(1):105. doi: 10.1186/s12872-019-1076-5.

DOI:10.1186/s12872-019-1076-5
PMID:31064347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6505272/
Abstract

BACKGROUND

The function of deiodinases - selenoproteins converting thyroid hormones may be disturbed by oxidative stress accompanying heart failure. Selenium (Se) may be used by glutathione peroxidase, leading to a lack of deiodinase and triiodothyronine (T3). The aim of the study was the evaluation of the prevalence and clinical significance of low T3 syndrome in heart failure and the assessment of the association of low fT3 and Se deficiency.

METHODS

The study group consisted of 59 consecutive patients hospitalized due to decompensated HFrEF NYHA III or IV. Exclusion criteria were: thyroid dysfunction, severe systemic disease, treatment with amiodarone, steroids or propranolol. Group A included 9 patients with low free T3 (fT3) concentration below 3.1 pmol/L. Group B consisted of the remaining 50 patients with normal fT3 levels.

RESULTS

The prevalence of low T3 syndrome was 15.3%. The prevalence of Se deficiency was 74.6%. We demonstrated correlations between fT3 and main clinical variables (i.e. NT-proBNP, LVEF, hsCRP), but we did not find correlation between fT3 and the Se level. Kaplan-Meier survival analysis showed lower survival probability in patients with low fT3 (p < 0.001).

CONCLUSIONS

Low T3 syndrome is frequently found in patients with HFrEF and is associated with a poor outcome. We did not identify any significant correlation between Se and fT3 level.

摘要

背景

伴随心力衰竭发生的氧化应激可能会干扰将甲状腺激素转化为活性形式的脱碘酶 - 硒蛋白的功能。硒(Se)可能会被谷胱甘肽过氧化物酶消耗,导致脱碘酶和三碘甲状腺原氨酸(T3)缺乏。本研究旨在评估心力衰竭患者中低 T3 综合征的患病率和临床意义,并评估低游离 T3(fT3)与 Se 缺乏的相关性。

方法

研究组包括 59 例因失代偿性射血分数降低心衰(HFrEF)NYHA III 或 IV 级而住院的连续患者。排除标准为:甲状腺功能障碍、严重全身性疾病、使用胺碘酮、皮质类固醇或普萘洛尔。A 组包括游离 T3(fT3)浓度低于 3.1 pmol/L 的 9 例患者。B 组由其余 50 例 fT3 水平正常的患者组成。

结果

低 T3 综合征的患病率为 15.3%。Se 缺乏的患病率为 74.6%。我们证实了 fT3 与主要临床变量(即 NT-proBNP、LVEF、hsCRP)之间存在相关性,但未发现 fT3 与 Se 水平之间存在相关性。Kaplan-Meier 生存分析显示,fT3 水平较低的患者生存概率较低(p<0.001)。

结论

低 T3 综合征在 HFrEF 患者中较为常见,与不良预后相关。我们未发现 Se 与 fT3 水平之间存在任何显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fc/6505272/db63cbd17e18/12872_2019_1076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fc/6505272/f06f9c0b8f0f/12872_2019_1076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fc/6505272/db63cbd17e18/12872_2019_1076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fc/6505272/f06f9c0b8f0f/12872_2019_1076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fc/6505272/db63cbd17e18/12872_2019_1076_Fig2_HTML.jpg

相似文献

1
Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study.低三碘甲状腺原氨酸综合征与硒缺乏——在晚期心力衰竭中被低估的角色?一项单中心的初步研究。
BMC Cardiovasc Disord. 2019 May 7;19(1):105. doi: 10.1186/s12872-019-1076-5.
2
Low triiodothyronine syndrome and serum selenium status in the course of acute myocardial infarction.
Pol Merkur Lekarski. 2019 Aug 30;47(278):45-51.
3
Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure.硒缺乏与急性心肌梗死和慢性心力衰竭患者甲状腺谱变化的动态关系。
Kardiol Pol. 2019 Aug 23;77(7-8):674-682. doi: 10.33963/KP.14822. Epub 2019 May 5.
4
[Low T3 syndrome in multiple trauma patients--a phenomenon or important pathogenetic factor?].[多发伤患者的低T3综合征——一种现象还是重要的致病因素?]
Med Klin (Munich). 1999 Oct 15;94 Suppl 3:66-9. doi: 10.1007/BF03042196.
5
Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.低 T3 综合征与 NT-proBNP 联合应用作为急性失代偿性心力衰竭患者死亡的预测因子。
BMC Endocr Disord. 2021 Jul 2;21(1):140. doi: 10.1186/s12902-021-00801-x.
6
Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.短期多巴酚丁胺输注治疗对急性心力衰竭恶化伴低三碘甲状腺原氨酸综合征患者甲状腺激素谱和血液动力学参数的影响。
J Investig Med. 2012 Aug;60(6):907-10. doi: 10.2310/JIM.0b013e31825cec9c.
7
Association Between Low T3 Syndrome and Poor Prognosis in Adult Patients With Acute Myocarditis.低三碘甲状腺原氨酸综合征与成人急性心肌炎患者预后不良的相关性。
Front Endocrinol (Lausanne). 2021 Mar 8;12:571765. doi: 10.3389/fendo.2021.571765. eCollection 2021.
8
Euthyroid sick syndrome and nutritional status are correlated with hyposelenemia in hemodialysis patients.甲状腺功能正常的病态综合征和营养状况与血液透析患者的低硒血症相关。
Int J Artif Organs. 2011 Jul;34(7):577-83. doi: 10.5301/IJAO.2011.8474.
9
Analysis of the Incidence of Euthyroid Sick Syndrome in Comprehensive Intensive Care Units and Related Risk Factors.综合性重症监护病房中甲状腺功能正常病态综合征的发生率及相关危险因素分析。
Front Endocrinol (Lausanne). 2021 Jun 9;12:656641. doi: 10.3389/fendo.2021.656641. eCollection 2021.
10
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.低 T3 综合征可作为慢性淋巴细胞白血病不良预后的预测指标。
Int J Cancer. 2018 Aug 1;143(3):466-477. doi: 10.1002/ijc.31327. Epub 2018 Mar 2.

引用本文的文献

1
Low T3 syndrome is associated with 30-day mortality in adult patients with fulminant myocarditis.低 T3 综合征与暴发性心肌炎成年患者的 30 天死亡率相关。
Front Endocrinol (Lausanne). 2023 May 31;14:1164444. doi: 10.3389/fendo.2023.1164444. eCollection 2023.
2
Non-thyroidal illness syndrome and the prognosis of heart failure: a systematic review and meta-analysis.非甲状腺疾病综合征与心力衰竭的预后:一项系统评价和荟萃分析。
Endocr Connect. 2023 Jul 5;12(8):e230048. doi: 10.1530/EC-23-0048.
3
FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007-2012.

本文引用的文献

1
Oxidative stress and cardiovascular disease: new insights.氧化应激与心血管疾病:新的认识。
Kardiol Pol. 2018;76(4):713-722. doi: 10.5603/KP.a2018.0071. Epub 2018 Mar 14.
2
Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study.三碘甲状腺原氨酸替代疗法对慢性稳定型心力衰竭合并低三碘甲状腺原氨酸综合征患者的影响:一项随机、双盲、安慰剂对照研究。
ESC Heart Fail. 2015 Mar;2(1):5-11. doi: 10.1002/ehf2.12025. Epub 2015 Mar 30.
3
Usefulness of Serum Triiodothyronine (T3) to Predict Outcomes in Patients Hospitalized With Acute Heart Failure.
FT3/FT4 比值与全因死亡率、心血管死亡率和心血管疾病风险相关:NHANES 2007-2012。
Front Endocrinol (Lausanne). 2022 Aug 18;13:964822. doi: 10.3389/fendo.2022.964822. eCollection 2022.
4
Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.低 T3 综合征与 NT-proBNP 联合应用作为急性失代偿性心力衰竭患者死亡的预测因子。
BMC Endocr Disord. 2021 Jul 2;21(1):140. doi: 10.1186/s12902-021-00801-x.
5
Thyroid Dysfunction and Dysmetabolic Syndrome: The Need for Enhanced Thyrovigilance Strategies.甲状腺功能障碍与代谢综合征:加强甲状腺监测策略的必要性。
Int J Endocrinol. 2021 Mar 29;2021:9641846. doi: 10.1155/2021/9641846. eCollection 2021.
6
Correction to: Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study.对《低三碘甲状腺原氨酸综合征与硒缺乏——晚期心力衰竭中被低估的因素?一项单中心试点研究》的勘误
BMC Cardiovasc Disord. 2019 Jun 3;19(1):133. doi: 10.1186/s12872-019-1118-z.
血清三碘甲状腺原氨酸(T3)对预测急性心力衰竭住院患者预后的价值
Am J Cardiol. 2017 Feb 15;119(4):599-603. doi: 10.1016/j.amjcard.2016.10.045. Epub 2016 Nov 16.
4
Thyroid hormones and cardiovascular disease.甲状腺激素与心血管疾病。
Nat Rev Cardiol. 2017 Jan;14(1):39-55. doi: 10.1038/nrcardio.2016.174. Epub 2016 Nov 4.
5
Non-thyroidal illness syndrome in patients with cardiovascular diseases: A systematic review and meta-analysis.心血管疾病患者的非甲状腺疾病综合征:一项系统评价和荟萃分析。
Int J Cardiol. 2017 Jan 1;226:1-10. doi: 10.1016/j.ijcard.2016.10.039. Epub 2016 Oct 18.
6
[The relation between the low T3 syndrome in the clinical course of myocardial infarction and heart failure].[心肌梗死临床过程中的低T3综合征与心力衰竭的关系]
Pol Merkur Lekarski. 2016 Jun;40(240):380-3.
7
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
8
Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure.急性失代偿性心力衰竭住院患者入院时的甲状腺功能与预后
J Cardiol. 2015 Sep;66(3):205-11. doi: 10.1016/j.jjcc.2015.04.006. Epub 2015 May 14.
9
Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study.长期左甲状腺素钠(T3)治疗稳定型收缩性心力衰竭患者:一项随机、双盲、交叉、安慰剂对照的干预研究。
Clin Endocrinol (Oxf). 2015 Dec;83(6):931-7. doi: 10.1111/cen.12648. Epub 2014 Dec 17.
10
[Thyroid hormone and the cardiovascular system].[甲状腺激素与心血管系统]
Pol Merkur Lekarski. 2014 Sep;37(219):170-4.